IRIS
PIGNATA, SALVATORE ANTONIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.003
NA - Nord America 926
AS - Asia 176
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 2
SA - Sud America 1
Totale 2.113
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 924
IE - Irlanda 316
IT - Italia 267
SE - Svezia 250
CN - Cina 133
PL - Polonia 46
DE - Germania 38
FR - Francia 38
IN - India 32
FI - Finlandia 12
GB - Regno Unito 10
BE - Belgio 9
VN - Vietnam 8
AT - Austria 5
NL - Olanda 4
A1 - Anonimo 3
AU - Australia 2
CA - Canada 2
IR - Iran 2
RO - Romania 2
A2 - ???statistics.table.value.countryCode.A2??? 1
CH - Svizzera 1
CL - Cile 1
ES - Italia 1
EU - Europa 1
HK - Hong Kong 1
MK - Macedonia 1
NO - Norvegia 1
RU - Federazione Russa 1
UA - Ucraina 1
Totale 2.113
Salva come PNG Salva come JPEG
Città #
Dublin 314
Chandler 300
Nyköping 181
Ashburn 68
Princeton 54
Messina 49
Warsaw 46
Beijing 44
Medford 42
Dearborn 35
Bremen 34
Des Moines 34
Jacksonville 29
Ann Arbor 27
Hyderabad 22
Cambridge 12
Rome 12
New York 11
Jinan 10
Brussels 9
Dong Ket 8
Falls Church 8
Shenyang 8
Milan 7
Nanjing 7
Pune 7
Wilmington 7
Hebei 6
Nanchang 6
Redwood City 6
Vittoria 6
Fuzhou 5
Santa Domenica 5
Seattle 5
Taizhou 5
Tianjin 5
Tremestieri Etneo 5
Turin 5
Vienna 5
Changsha 4
Hangzhou 4
Leeds 4
Ningbo 4
Palermo 4
San Mateo 4
Waverly Hall 4
Zhengzhou 4
Boardman 3
Haikou 3
Helsinki 3
Lanzhou 3
Los Angeles 3
Strasbourg 3
Torino 3
Ancona 2
Bari 2
Brescia 2
Brindisi 2
Catania 2
Clearwater 2
Guangzhou 2
Hefei 2
Iasi 2
Leawood 2
Norwalk 2
Nürnberg 2
Osimo 2
Pescara 2
Pleasant Hill 2
Ravenna 2
Santa Teresa Di Riva 2
Agliana 1
Angri 1
Ardabil 1
Augusta 1
Bengaluru 1
Bergamo 1
Berlin 1
Birmingham 1
Boulder 1
Castelfranco Di Sopra 1
Castelnuovo Rangone 1
Chaoyang 1
Chengdu 1
Dallas 1
Decimomannu 1
Duncan 1
Edinburgh 1
Fairfield 1
Florence 1
Floridia 1
Follonica 1
Gardone Val Trompia 1
Geelong 1
Giarre 1
Hong Kong 1
Houston 1
Ivrea 1
Lancaster 1
London 1
Totale 1.565
Salva come PNG Salva come JPEG
Nome #
EMIAGENESIA TIROIDEA, MORBO DI BASEDOW-GRAVES E CARCINOMA DIFFERENZIATO DELLA TIROIDE: UN’ASSOCIAZIONE MOLTO RARA. 173
99mTc-Methoxy-Isobutyl-Isonitrile Scintigraphy Is a Useful Tool for Assessing the Risk of Malignancy in Thyroid Nodules with Indeterminate Fine-Needle Cytology 97
Abnormal 99mTc-MIBI Uptakein left lung mimicking a neoplastic lesion in a young woman with nodular goiter. A rare pitfall of 99mTc-MIBI 77
Prognostic Validity of Dual Tracer PET/CT in the PRRT Enrollment of GEP-NET Patients 77
Association of parathyroid carcinoma and thyroid disorders: A clinical review 73
Thyroid remnant ablation in differentiated thyroid cancer: searching for the most effective radioiodine activity and stimulation strategy ina real life scenario 66
Braf V600E and 99m-TC MIBI scintigraphy are usefull diagnostic tools in identifying metastatic differentiated thyroid cancer patients refractory to radioiodine therapy. 65
Usefulness of PET-CT scan in recurrent thyroid cancer 64
Peptide Receptor Radionuclide Therapy and Somatostatin 'cold' Analogues Therapy in the Treatment of GEP-NET Patients: Our Center’ Experience 63
99mTc-methoxy-isobutyl-isonitrile (MIBI) scintigraphy is an useful and cost-effective tool for assessing the risk of malignancy in thyroid nodules with indeterminate fine needle cytology (FNAC) 62
Complete Response in a Pancreatic Nen with Liver Metastasis after PRRT in association with Lanreotide Autogel/depot: Design of the Prelude Study 62
Differentiating malignant from benign thyroid nodules with indeterminate cytology by 99mTc-MIBI scan: A new quantitative method for improving diagnostic accuracy 61
Renal Function Evaluation in PRRT Retreatments 57
A Single Centre Experience with 223-Radium-Dichloride ((RaCl2)-Ra-223) Therapy 54
Thyroid remnant ablation in differentiated thyroid cancer: searching for the most effective radioiodine activity and stimulation strategy in a real-life scenario 52
un caso di carcinoma delle paratiroidi associato ad adenoma autonomo omolaterale della tiroide 52
Combined BRAFV600Eanalysis and99mTc-MIBI scintigraphy can be a useful diagnostic tool in differentiated thyroid cancer patients with incomplete bio-chemical response to first radioiodine therapy (RAIT): a pilot investigation 52
223RA-dichloride use in patients affected by bone metastases from castration-resistant prostate cancer: single centre experience 52
Axitinib after Sunitinib in metastatic renal cancer: Preliminary results from Italian "Real-World" SAX Study 52
99mTc-Methoxy-Isobutil-Isonitrile (MIBI) scintigraphy is an useful and cost-effective tool for assessing the risk of malignancy in thyroid nodules with indeterminate fine needle cytology (FNAC) 51
Complete response in a pancreatic NEN with liver metastasis after PRRT in association with lanreotide autogel/depot 51
Comparing radioiodine abdominal absorbed dose in differentiated thyroid cancer patients undergone thyroid remnant ablation in either levo-thyroxine withdrawal or after rhtsh stimulation 49
BRAFV600E and 99mTc-MIBI scintigraphy are usefull diagnostic tools in identifying metastatic differentiated thyroid cancer patients refractory to radioiodine therapy 48
Theranosticsin nuclear medicine and oncology 48
Prognostic Validity of Dual Tracer PET/CT In The PRRT Enrollment of GEP-NET Patients 44
Can peptide receptor radionuclide therapy (PRRT) be useful in radioiodine-refractory differentiated thyroid cancer? 43
The sensitivity and positive predictive value (PPV) of I-131-post-therapy whole body scan is higher than serum Tg values in detecting metastases in early stage of differentiated thyroid cancer patients 42
Is dual tracer PET/CT a prognostic biomarker in the PRRT enrollment of GEP-NET patients? 42
PRRT retreatments: renal function evaluation 42
From clinical trials to the front line: Vinflunine for treatment of urothelial cell carcinoma at the National Cancer Institute of Naples 41
Sequencing radium 223 and other life-prolonging agents in castration-resistant prostate cancer patients 40
Post-operative radioiodine therapy (RaIT) as adjuvant therapy in low–intermediate risk differentiated thyroid cancer 38
Very early PSA response to abiraterone in mCRPC patients: A novel prognostic factor predicting overall survival 34
Predictive Comprehensive Geriatric Assessment in elderly prostate cancer patients: The prospective observational scoop trial results 32
Fracture risk and survival outcomes in metastatic castration-resistant prostate cancer patients sequentially treated with abiraterone acetate and RADIUM-223 32
The additional value of 18F-FDG PET and MRI in patients with glioma: A review of the literature from 2015 to 2020 31
Corrigendum: Pazopanib in metastatic renal cancer: A "real-world" experience at national cancer institute "Fondazione G. Pascale" [Front. Pharmacol., 7, 287, (2016)] doi: 10.3389/fphar.2016.00287 30
Association of Upfront Peptide Receptor Radionuclide Therapy With Progression-Free Survival Among Patients With Enteropancreatic Neuroendocrine Tumors 27
null 24
Pazopanib in metastatic renal cancer: A "real-world" experience at National Cancer Institute "Fondazione G. Pascale" 24
null 23
Undetectable or low (< 1 ng/ml) postsurgical thyroglobulin values do not rule out metastases in early stage differentiated thyroid cancer patients 20
null 16
Sequencing Life-Prolonging Agents in Castration-Resistant Prostate Cancer Patients: Comparison of Sequences With and Without 223Ra 13
Recombinant human thyrotropin (rhTSH) versus Levo-thyroxine withdrawal in radioiodine therapy of differentiated thyroid cancer patients: differences in abdominal absorbed dose 12
Sequencing radium 223 (RA223) for metastatic castration-resistant prostate cancer (mCRPC) patients (pts) in the daily practice: Preliminary results from a retrospective study in Italian centers 11
Peptide receptor radionuclide therapy plus somatostatin analogues for a neuroendocrine tumour combined and maintenance treatment 10
Association of Upfront Peptide Receptor Radionuclide Therapy With Progression-Free Survival Among Patients With Enteropancreatic Neuroendocrine Tumors 7
Totale 2.236
Salva come PNG Salva come JPEG
Categoria #
all - tutte 9.268
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.268
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201915 0 0 0 0 0 0 0 0 0 0 13 2
2019/2020196 8 2 2 7 1 32 13 33 10 37 19 32
2020/2021281 19 10 77 10 41 6 10 33 32 12 19 12
2021/2022359 6 35 6 7 21 10 8 28 5 39 49 145
2022/20231.015 88 131 49 85 72 92 17 59 376 10 22 14
2023/2024219 21 26 13 37 25 42 16 12 0 27 0 0
Totale 2.236